BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26201606)

  • 21. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.
    Chen Q; Espey MG; Krishna MC; Mitchell JB; Corpe CP; Buettner GR; Shacter E; Levine M
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13604-9. PubMed ID: 16157892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer.
    Moser JC; Rawal M; Wagner BA; Du J; Cullen JJ; Buettner GR
    Redox Biol; 2013; 2():22-7. PubMed ID: 24396727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.
    Chen Q; Espey MG; Sun AY; Pooput C; Kirk KL; Krishna MC; Khosh DB; Drisko J; Levine M
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11105-9. PubMed ID: 18678913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells.
    Brandt KE; Falls KC; Schoenfeld JD; Rodman SN; Gu Z; Zhan F; Cullen JJ; Wagner BA; Buettner GR; Allen BG; Berg DJ; Spitz DR; Fath MA
    Redox Biol; 2018 Apr; 14():82-87. PubMed ID: 28886484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of labile iron in the toxicity of pharmacological ascorbate.
    Du J; Wagner BA; Buettner GR; Cullen JJ
    Free Radic Biol Med; 2015 Jul; 84():289-295. PubMed ID: 25857216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly.
    Shenoy N; Creagan E; Witzig T; Levine M
    Cancer Cell; 2018 Nov; 34(5):700-706. PubMed ID: 30174242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of hydroperoxide metabolism enhance ascorbate-induced cytotoxicity.
    Olney KE; Du J; van 't Erve TJ; Witmer JR; Sibenaller ZA; Wagner BA; Buettner GR; Cullen JJ
    Free Radic Res; 2013 Mar; 47(3):154-63. PubMed ID: 23205739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy.
    Chen P; Yu J; Chalmers B; Drisko J; Yang J; Li B; Chen Q
    Anticancer Drugs; 2012 Apr; 23(4):437-44. PubMed ID: 22205155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic Ascorbate Primes Pancreatic Cancer Cells for Death by Rewiring Cellular Energetics and Inducing DNA Damage.
    Buranasudja V; Doskey CM; Gibson AR; Wagner BA; Du J; Gordon DJ; Koppenhafer SL; Cullen JJ; Buettner GR
    Mol Cancer Res; 2019 Oct; 17(10):2102-2114. PubMed ID: 31337671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of ascorbate induces expression of brain derived neurotrophic factor in SH-SY5Y neuroblastoma cells after peroxide insult, which is associated with increased survival.
    Grant MM; Barber VS; Griffiths HR
    Proteomics; 2005 Feb; 5(2):534-40. PubMed ID: 15627972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma.
    O'Leary BR; Houwen FK; Johnson CL; Allen BG; Mezhir JJ; Berg DJ; Cullen JJ; Spitz DR
    Radiat Res; 2018 May; 189(5):456-465. PubMed ID: 29547353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ascorbate supplement reduces oxidative stress in dyslipidemic patients undergoing apheresis.
    Chien CT; Chang WT; Chen HW; Wang TD; Liou SY; Chen TJ; Chang YL; Lee YT; Hsu SM
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1111-7. PubMed ID: 15072991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress.
    Klingelhoeffer C; Kämmerer U; Koospal M; Mühling B; Schneider M; Kapp M; Kübler A; Germer CT; Otto C
    BMC Complement Altern Med; 2012 May; 12():61. PubMed ID: 22551313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back.
    González-Montero J; Chichiarelli S; Eufemi M; Altieri F; Saso L; Rodrigo R
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance.
    Cullen JJ; Spitz DR; Buettner GR
    Free Radic Biol Med; 2011 Jun; 50(12):1726-7. PubMed ID: 21459141
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular mechanisms of pharmacological doses of ascorbate on cancer cells.
    Venturelli S; Sinnberg TW; Niessner H; Busch C
    Wien Med Wochenschr; 2015 Jun; 165(11-12):251-7. PubMed ID: 26065536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxiredoxin 2 oxidation reveals hydrogen peroxide generation within erythrocytes during high-dose vitamin C administration.
    Pearson AG; Pullar JM; Cook J; Spencer ES; Vissers MC; Carr AC; Hampton MB
    Redox Biol; 2021 Jul; 43():101980. PubMed ID: 33905956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redox modulation of oxidatively-induced DNA damage by ascorbate enhances both in vitro and ex-vivo DNA damage formation and cell death in melanoma cells.
    Najeeb HA; Sanusi T; Saldanha G; Brown K; Cooke MS; Jones GD
    Free Radic Biol Med; 2024 Mar; 213():309-321. PubMed ID: 38262545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pharmacological ascorbate on hemoglobin-induced cancer cell proliferation.
    Lu N; Ding Y; Tian R; Yang Z; Chen J; Peng YY
    Int J Biol Macromol; 2016 Nov; 92():1215-1219. PubMed ID: 27527692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation.
    Lu YX; Wu QN; Chen DL; Chen LZ; Wang ZX; Ren C; Mo HY; Chen Y; Sheng H; Wang YN; Wang Y; Lu JH; Wang DS; Zeng ZL; Wang F; Wang FH; Li YH; Ju HQ; Xu RH
    Theranostics; 2018; 8(5):1312-1326. PubMed ID: 29507622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.